MedTrace Logo

Improving Effective Contraceptive Use Among Opioid-maintained Women: Stage II

NCT02411357 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 138

Last updated 2023-02-10

Study results available
· View outcomes & findings →

Summary

Nearly 9 of every 10 pregnant opioid-dependent women report that the current pregnancy was unintended and the majority of non-pregnant opioid-maintained women do not use contraception or use less effective methods like condoms. This proposal aims to further test a novel contraceptive management program to increase use of more effective contraceptives among opioid-maintained women at risk of unintended pregnancy.

Conditions

  • Contraceptive Usage
  • Opioid Dependence

Interventions

BEHAVIORAL

Treatment as usual

General information about contraceptive options and referral to contraceptive service providers

BEHAVIORAL

WHO contraception protocol

World Health Organization's contraception protocol

BEHAVIORAL

Incentives

Financial incentives contingent on follow-up visit attendance

Sponsors & Collaborators

  • University of Vermont

    lead OTHER

Principal Investigators

  • Sarah H. Heil, Ph.D. · University of Vermont

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
44 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-05-05
Primary Completion
2019-03-06
Completion
2019-09-09

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02411357 on ClinicalTrials.gov